Alberta provides treatment for genetic disorder
Poll
Yes
By Dale Woodard on January 30, 2021.
Alberta families of children with a rare genetic disorder received some good news on the treatment front Wednesday when it was announced children suffering from spinal muscular atrophy may now be eligible to receive funding for gene replacement therapy treatment. Alberta’s government is working with Novartis Pharmaceuticals Canada Inc. to provide interim patient access to Zolgensma. Spinal muscular atrophy is a rare and progressive genetic disorder that causes muscle wasting. Alberta children with SMA and who may become ineligible for the treatment while waiting for the final approval processes to be completed will be considered for funding on a case-by-case basis.
Florida State University News
Faculty and Staff Briefs: January 2021
Published:
HONORS AND AWARDS
Gregory J. Harris, Ph.D. (College of Human Sciences) and
Earl Levison (Student Affairs) were recently selected as recipients of the 2021 Dr. Martin Luther King Jr. Distinguished Service Award presented by the FSU Division of Student Affairs and the Center for Leadership and Social Change. The Dr. Martin Luther King, Jr. Distinguished Service Award was established in 1986 to honor a faculty member, administrator or staff member for their outstanding service in keeping with the principles and ideals of Dr. King. The honor also comes with a $1,000 stipend.